BioCentury
ARTICLE | Clinical News

Faropenem medoxomil infectious data

September 24, 2007 7:00 AM UTC

In a U.S. surveillance trial, faropenem was the most active oral beta-lactam against S. pneumoniae, including penicillin-resistant and multi-drug-resistant strains. The study analyzed 393 S. pneumonia...